1. The Skin Microbiome and its Significance for Dermatologists

   • Cleo Whiting
   • Sara Abdel Azim
   • Adam Friedman

   Leading Article 22 January 2024 Pages: 169 - 177

   

2. Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors

   • Richard W. Kim
   • Megan Lam
   • Aaron M. Drucker

   Review Article 12 January 2024 Pages: 179 - 193

3. Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update

   • Meropi Karakioulaki
   • Kilian Eyerich
   • Aikaterini Patsatsi

   Review Article Open access 29 December 2023 Pages: 195 - 212

   

4. Recent Advances in Treatment of Systemic Sclerosis and Morphea

   • Noelle Teske
   • Nicole Fett

   Review Article 12 December 2023 Pages: 213 - 226

   

5. Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review

   • Angela Lo
   • Brittany Thompson
   • Naveed Sami

   Review Article 13 December 2023 Pages: 227 - 242

6. Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options

   • Tejas P. Joshi
   • Madeleine Duvic

   Review Article 30 December 2023 Pages: 243 - 259

   

7. Pressure and Skin: A Review of Disease Entities Driven or Influenced by Mechanical Pressure

   • Wei-Chen Chien
   • Tsen-Fang Tsai

   Review Article 30 December 2023 Pages: 261 - 280

   

8. Mucocutaneous Manifestations of Recreational Drug Use

   • Carolina V. Alexander-Savino
   • Ginat W. Mirowski
   • Donna A. Culton

   Review Article 13 January 2024 Pages: 281 - 297

   

9. Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

   • Brett King
   • Jennifer Soung
   • Alexandre Lejeune

   Original Research Article Open access 23 January 2024 Pages: 299 - 314

   

10. Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial

    • Luis Puig
    • Antonio Costanzo
    • Curdin Conrad

    Original Research Article Open access 07 October 2023 Pages: 315 - 325

    

11. Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year

    • Wilson Hu
    • Michele Thornton
    • Robert A. Livingston

    Original Research Article Open access 19 January 2024 Pages: 327 - 332

12. Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study

    • Tiago Torres
    • Andrea Chiricozzi
    • Paolo Gisondi

    Original Research Article Open access 24 January 2024 Pages: 333 - 342

13. Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program

    • Jill T. Shah
    • William Mark Richardson
    • Alisa N. Femia

    Research Letter 02 February 2024 Pages: 343 - 345